GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » Cash Conversion Cycle

China Healthwise Holdings (HKSE:00348) Cash Conversion Cycle : 177.37 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

China Healthwise Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 14.25.
China Healthwise Holdings's Days Inventory for the six months ended in Dec. 2023 was 232.06.
China Healthwise Holdings's Days Payable for the six months ended in Dec. 2023 was 68.94.
Therefore, China Healthwise Holdings's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was 177.37.


China Healthwise Holdings Cash Conversion Cycle Historical Data

The historical data trend for China Healthwise Holdings's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Healthwise Holdings Cash Conversion Cycle Chart

China Healthwise Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.38 228.77 198.81 167.80 150.13

China Healthwise Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 228.93 154.31 167.72 143.50 177.37

Competitive Comparison of China Healthwise Holdings's Cash Conversion Cycle

For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Healthwise Holdings's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where China Healthwise Holdings's Cash Conversion Cycle falls into.



China Healthwise Holdings Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

China Healthwise Holdings's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=14.13+235.79-99.79
=150.13

China Healthwise Holdings's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=14.25+232.06-68.94
=177.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Healthwise Holdings  (HKSE:00348) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


China Healthwise Holdings Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


China Healthwise Holdings (HKSE:00348) Business Description

Traded in Other Exchanges
N/A
Address
168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Executives
Eternity Investment Limited 2201 Interest of corporation controlled by you
Heng Tai Consumables Group Limited 2201 Interest of corporation controlled by you
Heng Tai Finance Limited 2101 Beneficial owner
Lei Hong Wai 2101 Beneficial owner

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines